---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-396752"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-09-21T20:47:49+00:00"
generated_at: "2026-09-21T20:49:10.132851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health effects 1-for-15 reverse stock split, eliminates 14 preferred series

## Summary
- Reverse stock split effective Sept 17, 2026; post-split common shares outstanding approx 520,088.
- Filed Certificate of Elimination for 14 series of preferred stock with zero shares outstanding.
- All eliminated preferred shares had been converted, exchanged, or disposed of prior to Sept 15, 2026.
- Preferred shares returned to authorized but undesignated preferred stock; no impact on common equity.

## SEC filing metadata
- accession: 0001193125-26-396752
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-09-21T20:47:49+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.03, 8.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526396752/0001193125-26-396752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526396752/d79729d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-396752
- JSON: https://secwatch.observer/filing/0001193125-26-396752.json
- Plain text: https://secwatch.observer/filing/0001193125-26-396752.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.